Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel photo-thermal method for imidazopyridines using FePc. Reduces noble metal dependency and enhances supply chain stability for pharma intermediates.
Patent CN114591217A reveals a novel lactone-based route for 6,6-dimethyl-3-azabicyclo[3.1.0]hexane, offering superior atom economy and cost reduction in API manufacturing for antiviral drugs.
New patent CN105399736B offers high purity brexpiprazole intermediate synthesis with mild conditions ensuring supply chain reliability and cost reduction for pharmaceutical manufacturing.
Patent CN101456838B details a metal-free chiral phosphoric acid catalyzed route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN102584596B reveals a low-cost method for antioxidant 3100. Enhances purity and reduces waste for reliable polymer additives supply chains.
Patent CN1498881A reveals a novel aqueous-phase synthesis for polyhaloalkylaryls, offering significant cost reduction in agrochemical intermediate manufacturing and improved supply chain reliability.
Patent CN109295026B reveals a high-efficiency enzymatic route for Zalcitabine. Discover cost-effective biocatalysis solutions for nucleoside analogues manufacturing.
Patent CN114773337A reveals a novel one-step cyclization for zolpidem, offering high purity and reduced genotoxic risks for reliable pharmaceutical intermediate supply chains.
Patent CN1642930A reveals an inorganic base-catalyzed method for high-purity CCR5 antagonist intermediates, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN104402701A reveals water-based strawberry acid synthesis. Delivers green chemistry benefits and supply chain stability for flavor manufacturers globally.
Patent CN1260364C reveals a novel enzymatic hydrolysis using bulky esters for high-purity beta-amino acids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN114835541A details a Pd-catalyzed method for high-yield chiral allenoic acids. Offers superior atom economy and scalability for pharmaceutical intermediate manufacturing.
Patent CN105566202A reveals a novel Rh-Cu catalyzed one-pot synthesis for high-purity indole derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN103648645B details a novel Pd(I) dimer preparation method offering high yields and recyclable starting materials for cost-effective pharmaceutical intermediate manufacturing.
Patent CN113717090B reveals a metal-free catalytic route for trifluoromethyl indole acetonitriles. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN113174377B reveals a stable carbonyl reductase mutant for synthesizing (2R,3S)-MPGM with 100% theoretical yield, offering significant cost reduction in API manufacturing.
Novel Cu-Ni catalyzed solvent-free method for tris(3,6-dioxaheptyl)amine. High yield, low impurities. Cost-effective phase-transfer catalyst production.
Discover the novel ionic liquid catalyzed synthesis of Prulifloxacin. High purity API intermediate manufacturing with reduced environmental impact and scalable processes.
Patent CN103539750A details a novel nano-cuprous oxide catalyzed route for Rufinamide, offering safer room temperature reactions and streamlined purification for reliable API manufacturing.
Patent CN110818545B reveals a robust method for substituted aryl ketones using oxygen-tolerant catalysts, enabling cost-effective pharma intermediate manufacturing.